TubeMogul Hosts Programmatic Leadership Summit Dedicated To Chinese Market
Aug 25, 2016 11:30 am UTC| Business
SHANGHAI, China, Aug. 25, 2016 -- TubeMogul (NASDAQ:TUBE), an enterprise software company for brand advertising, today hosts its first educational summit in China. The half-day event, bringing together over 50 brands,...
Provision Interactive Pumps-Up Ad Sales Efforts with TSQ Worldwide
Aug 25, 2016 11:30 am UTC| Business
CHATSWORTH, Calif., Aug. 25, 2016 -- Provision Interactive Technologies, Inc. ("Provision"), a subsidiary of Provision Holding, Inc. (OTCQB:PVHO), announced today that it has signed an agreement with New York-based TSQ...
Applied Materials to Host Analyst Day on Wednesday, September 21
Aug 25, 2016 11:30 am UTC| Business
SANTA CLARA, Calif., Aug. 25, 2016 -- Applied Materials, Inc. will hold its 2016 Analyst Day on Wednesday, September 21 in New York. Presentations by Applied’s management team will begin at 1:30 p.m. ET (10:30 a.m. PT)...
Radiance Visual Analytics Platform Wins Computer Technology Review’s MVP Award
Aug 25, 2016 11:30 am UTC| Business
WASHINGTON, Aug. 25, 2016 -- FTI Consulting, Inc. (NYSE:FCN), the global business advisory firm dedicated to helping organizations protect and enhance their enterprise value, today announced its FTI Technology segment...
NeuroDerm Announces Second Quarter 2016 Financial Results and Provides Corporate Update
Aug 25, 2016 11:25 am UTC| Business
REHOVOT, Israel, Aug. 25, 2016 -- NeuroDerm Ltd. (NASDAQ:NDRM), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) diseases, today announced financial results for the second...
Aug 25, 2016 11:20 am UTC| Business
$105.7 million Revenue for Q2 2016 $40.1 million net cash from operating activities for Q2 2016$31.1 million EBITDA for Q2 2016$2 million of cash as of June 30, 2016Positioned to weather difficult market Solid operational...
Aug 25, 2016 11:18 am UTC| Business
REHOVOT, Israel, Aug. 25, 2016 -- NeuroDerm Ltd. (Nasdaq:NDRM), a clinical stage pharmaceutical company developing drugs for central nervous system (CNS) disorders, today announced that it has initiated enrollment of...